Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

NLSP

NLS Pharmaceutics AG

Healthcare

Set alert

Price alert · NLSP

All alert types
2.91 0.00 0.00%
As of Dec 12, 2025
2.91 Day range 3.51
1.73 52-week range 24.32
YTD
-86.21%
1 year
-92.46%
Open
3.31
Prev close
2.91
Mkt cap
4.69M
Vol
113.99K
Avg vol
380.73K
EPS
-6.74
P/E
0.00
Div yield
0.00%
More statistics
Low
2.91
High
3.51
Forward P/E
-3.60
Beta
-0.52
Short ratio
0.15
Inst. own
19.40%
Dividend
0.00
Ex-div date
Earnings
Aug 21, 2024
50-d avg
3.46
200-d avg
5.96
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for NLSP has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-25.94 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.8×
FY 2017: -203×FY 2018: -3.5×FY 2019: -236×FY 2020: -196×FY 2021: -54.8×FY 2022: -61.4×FY 2023: -73.5×FY 2024: -0.8×
FY 2017 5y median -61.4× FY 2024
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2017 5y median 0.0× FY 2024
P/B 1.1×
FY 2017: -176×FY 2018: -0.0×FY 2019: -209×FY 2020: -62.0×FY 2021: 1207×FY 2022: 310×FY 2023: -102×FY 2024: 1.1×
FY 2017 5y median 1.1× FY 2024
P/FCF -0.4×
FY 2017: -251×FY 2018: -0.0×FY 2019: -6779×FY 2020: -764×FY 2021: -43.7×FY 2022: -73.2×FY 2023: -92.7×FY 2024: -0.4×
FY 2017 5y median -73.2× FY 2024
EV/EBITDA 0.0×
FY 2017: 0.0×FY 2018: 6.5×FY 2019: -2994×FY 2020: 8.0×FY 2021: -54.8×FY 2022: -65.1×FY 2023: -76.2×FY 2024: 0.0×
FY 2017 5y median -54.8× FY 2024
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2017 5y median 0.0× FY 2024
FCF Yield -268.9%
FY 2017: -0.4%FY 2018: -14775.1%FY 2019: -0.0%FY 2020: -0.1%FY 2021: -2.3%FY 2022: -1.4%FY 2023: -1.1%FY 2024: -268.9%
FY 2017 5y median -1.4% FY 2024

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2017 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2017 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2017 5y median 0.0% FY 2024
ROE -140.8%
FY 2017: 86.3%FY 2018: 0.1%FY 2019: 88.3%FY 2020: 31.9%FY 2021: -2202.5%FY 2022: -502.8%FY 2023: 137.8%FY 2024: -140.8%
FY 2017 5y median -140.8% FY 2024
ROIC -311.5%
FY 2017: -443.8%FY 2018: 0.2%FY 2019: 158.5%FY 2020: 54.5%FY 2021: -352.9%FY 2022: -261.7%FY 2023: 266.0%FY 2024: -311.5%
FY 2017 5y median -261.7% FY 2024
ROA -88.7%
FY 2017: -290.9%FY 2018: -3.5%FY 2019: -782.2%FY 2020: -236.2%FY 2021: -207.2%FY 2022: -177.8%FY 2023: -659.1%FY 2024: -88.7%
FY 2017 5y median -207.2% FY 2024

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2017 FY 2024
Operating Income 62.9%
FY 2017: 0.0%FY 2018: 99.9%FY 2019: -121593.5%FY 2020: 45.2%FY 2021: -415.8%FY 2022: -30.5%FY 2023: 23.7%FY 2024: 62.9%
FY 2017 FY 2024
EPS (diluted) -721.9%
FY 2017: 0.0%FY 2018: -5687.7%FY 2019: 98.5%FY 2020: -20.4%FY 2021: -37.3%FY 2022: -3.7%FY 2023: 61.9%FY 2024: -721.9%
FY 2017 FY 2024
Free Cash Flow 55.9%
FY 2017: 0.0%FY 2018: 49.7%FY 2019: 93.0%FY 2020: -283.9%FY 2021: -1953.2%FY 2022: 7.3%FY 2023: 30.2%FY 2024: 55.9%
FY 2017 FY 2024

Financial Health

Current Ratio 2.7×
FY 2017: 2.3×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 2.4×FY 2022: 2.8×FY 2023: 0.2×FY 2024: 2.7×
FY 2017 5y median 2.4× FY 2024
Quick Ratio 2.7×
FY 2017: 2.3×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 2.4×FY 2022: 2.8×FY 2023: 0.2×FY 2024: 2.7×
FY 2017 5y median 2.4× FY 2024
Debt / Equity 0.0×
FY 2017: -1.1×FY 2018: -0.8×FY 2019: -0.1×FY 2020: -0.2×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -0.2×FY 2024: 0.0×
FY 2017 5y median 0.0× FY 2024
Net Debt / EBITDA 0.5×
FY 2017: 0.0×FY 2018: 6.5×FY 2019: -1.4×FY 2020: 0.0×FY 2021: 0.5×FY 2022: 0.6×FY 2023: -0.1×FY 2024: 0.5×
FY 2017 5y median 0.5× FY 2024
Interest Coverage -29.2×
FY 2017: -6.5×FY 2018: -3.2×FY 2019: -5.1×FY 2020: -9.8×FY 2021: -174×FY 2022: -153×FY 2023: -81.3×FY 2024: -29.2×
FY 2017 5y median -81.3× FY 2024

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2017 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2017 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31